MA2A1_HUMAN - dbPTM
MA2A1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID MA2A1_HUMAN
UniProt AC Q16706
Protein Name Alpha-mannosidase 2
Gene Name MAN2A1
Organism Homo sapiens (Human).
Sequence Length 1144
Subcellular Localization Golgi apparatus membrane
Single-pass type II membrane protein .
Protein Description Catalyzes the first committed step in the biosynthesis of complex N-glycans. It controls conversion of high mannose to complex N-glycans; the final hydrolytic step in the N-glycan maturation pathway..
Protein Sequence MKLSRQFTVFGSAIFCVVIFSLYLMLDRGHLDYPRNPRREGSFPQGQLSMLQEKIDHLERLLAENNEIISNIRDSVINLSESVEDGPKSSQSNFSQGAGSHLLPSQLSLSVDTADCLFASQSGSHNSDVQMLDVYSLISFDNPDGGVWKQGFDITYESNEWDTEPLQVFVVPHSHNDPGWLKTFNDYFRDKTQYIFNNMVLKLKEDSRRKFIWSEISYLSKWWDIIDIQKKDAVKSLIENGQLEIVTGGWVMPDEATPHYFALIDQLIEGHQWLENNIGVKPRSGWAIDPFGHSPTMAYLLNRAGLSHMLIQRVHYAVKKHFALHKTLEFFWRQNWDLGSVTDILCHMMPFYSYDIPHTCGPDPKICCQFDFKRLPGGRFGCPWGVPPETIHPGNVQSRARMLLDQYRKKSKLFRTKVLLAPLGDDFRYCEYTEWDLQFKNYQQLFDYMNSQSKFKVKIQFGTLSDFFDALDKADETQRDKGQSMFPVLSGDFFTYADRDDHYWSGYFTSRPFYKRMDRIMESHLRAAEILYYFALRQAHKYKINKFLSSSLYTALTEARRNLGLFQHHDAITGTAKDWVVVDYGTRLFHSLMVLEKIIGNSAFLLILKDKLTYDSYSPDTFLEMDLKQKSQDSLPQKNIIRLSAEPRYLVVYNPLEQDRISLVSVYVSSPTVQVFSASGKPVEVQVSAVWDTANTISETAYEISFRAHIPPLGLKVYKILESASSNSHLADYVLYKNKVEDSGIFTIKNMINTEEGITLENSFVLLRFDQTGLMKQMMTKEDGKHHEVNVQFSWYGTTIKRDKSGAYLFLPDGNAKPYVYTTPPFVRVTHGRIYSEVTCFFDHVTHRVRLYHIQGIEGQSVEVSNIVDIRKVYNREIAMKISSDIKSQNRFYTDLNGYQIQPRMTLSKLPLQANVYPMTTMAYIQDAKHRLTLLSAQSLGVSSLNSGQIEVIMDRRLMQDDNRGLEQGIQDNKITANLFRILLEKRSAVNTEEEKKSVSYPSLLSHITSSLMNHPVIPMANKFSSPTLELQGEFSPLQSSLPCDIHLVNLRTIQSKVGNGHSNEAALILHRKGFDCRFSSKGTGLFCSTTQGKILVQKLLNKFIVESLTPSSLSLMHSPPGTQNISEINLSPMEISTFRIQLR
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
33PhosphorylationLDRGHLDYPRNPRRE
HHCCCCCCCCCCCCC
15.51-
42O-linked_GlycosylationRNPRREGSFPQGQLS
CCCCCCCCCCHHHHH
29.06OGP
70PhosphorylationAENNEIISNIRDSVI
HHCCHHHHHHHHHHH
31.6824719451
75PhosphorylationIISNIRDSVINLSES
HHHHHHHHHHCCCCC
18.3024275569
78N-linked_GlycosylationNIRDSVINLSESVED
HHHHHHHCCCCCCCC
35.0516335952
80PhosphorylationRDSVINLSESVEDGP
HHHHHCCCCCCCCCC
24.2823911959
82PhosphorylationSVINLSESVEDGPKS
HHHCCCCCCCCCCCC
27.6821082442
93N-linked_GlycosylationGPKSSQSNFSQGAGS
CCCCCCCCCCCCCCC
32.71UniProtKB CARBOHYD
105O-linked_GlycosylationAGSHLLPSQLSLSVD
CCCCCCCCCEECEEE
43.6655823709
192PhosphorylationNDYFRDKTQYIFNNM
HHHHCCHHHHHHHCE
30.7824719451
194PhosphorylationYFRDKTQYIFNNMVL
HHCCHHHHHHHCEEE
16.8324719451
207PhosphorylationVLKLKEDSRRKFIWS
EEEECHHHHCHHHHH
34.7730576142
218PhosphorylationFIWSEISYLSKWWDI
HHHHHHHHHHHHHHH
22.21-
307PhosphorylationLLNRAGLSHMLIQRV
HHHHCCHHHHHHHHH
13.1124719451
373UbiquitinationICCQFDFKRLPGGRF
EEEEEECCCCCCCCC
55.67-
407PhosphorylationARMLLDQYRKKSKLF
HHHHHHHHHHHCHHC
24.8619845377
4172-HydroxyisobutyrylationKSKLFRTKVLLAPLG
HCHHCCCEEEEEECC
26.99-
442PhosphorylationWDLQFKNYQQLFDYM
HHHHCCCHHHHHHHH
9.75-
473UbiquitinationDFFDALDKADETQRD
HHHHHHHHCCHHHHH
59.6029967540
484PhosphorylationTQRDKGQSMFPVLSG
HHHHHCCCCCCEECC
30.9329759185
490PhosphorylationQSMFPVLSGDFFTYA
CCCCCEECCCEEEEC
36.2329759185
509PhosphorylationHYWSGYFTSRPFYKR
CCCCCCCCCCHHHHH
18.49-
514PhosphorylationYFTSRPFYKRMDRIM
CCCCCHHHHHHHHHH
10.60-
523PhosphorylationRMDRIMESHLRAAEI
HHHHHHHHHHHHHHH
15.5026074081
532PhosphorylationLRAAEILYYFALRQA
HHHHHHHHHHHHHHH
11.38-
533PhosphorylationRAAEILYYFALRQAH
HHHHHHHHHHHHHHH
4.48-
614PhosphorylationILKDKLTYDSYSPDT
EECCCCCCCCCCCCC
17.2130576142
618PhosphorylationKLTYDSYSPDTFLEM
CCCCCCCCCCCCHHH
21.9130576142
621PhosphorylationYDSYSPDTFLEMDLK
CCCCCCCCCHHHCCC
33.2430576142
716UbiquitinationHIPPLGLKVYKILES
CCCCCCHHHHHHHHH
41.54-
723PhosphorylationKVYKILESASSNSHL
HHHHHHHHHCCCCCH
29.9721712546
733PhosphorylationSNSHLADYVLYKNKV
CCCCHHCEEEECCCC
6.1721712546
737UbiquitinationLADYVLYKNKVEDSG
HHCEEEECCCCCCCC
46.2429967540
7392-HydroxyisobutyrylationDYVLYKNKVEDSGIF
CEEEECCCCCCCCCE
42.73-
739UbiquitinationDYVLYKNKVEDSGIF
CEEEECCCCCCCCCE
42.7329967540
743PhosphorylationYKNKVEDSGIFTIKN
ECCCCCCCCCEEEEC
21.93-
747PhosphorylationVEDSGIFTIKNMINT
CCCCCCEEEECCCCC
29.17-
801UbiquitinationSWYGTTIKRDKSGAY
EEEEEEEEECCCCCE
53.07-
852PhosphorylationVTHRVRLYHIQGIEG
CCCEEEEEEEECCCC
6.06-
865PhosphorylationEGQSVEVSNIVDIRK
CCCEEEEEEEEEHHH
13.82-
887UbiquitinationMKISSDIKSQNRFYT
HHHCCCHHHCCCEEE
51.4829967540
933PhosphorylationQDAKHRLTLLSAQSL
HHHHHHHHHHHHHHH
26.1324275569
939PhosphorylationLTLLSAQSLGVSSLN
HHHHHHHHHCCCCCC
27.1424275569
944PhosphorylationAQSLGVSSLNSGQIE
HHHHCCCCCCCCCEE
29.2124275569
998PhosphorylationNTEEEKKSVSYPSLL
CCHHHHHCCCHHHHH
27.62-
1125N-linked_GlycosylationHSPPGTQNISEINLS
CCCCCCCCCEEEECC
39.3216335952

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of MA2A1_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of MA2A1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of MA2A1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CAN1_HUMANCAPN1physical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of MA2A1_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry.";
Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.;
J. Proteome Res. 4:2070-2080(2005).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-78 AND ASN-1125, AND MASSSPECTROMETRY.

TOP